rfhg_216920.1

Basic information about the TSS

---

TSS ID: rfhg_216920.1 Species: human Chr: chr19		Start: 58554554 End: 58554554 Strand: -
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3077560,EH38E1966454)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000600118.5:-84 BC047005:-84 GeneID: 27243 HGNC/MGI_ID: HGNC:30216 UniProt_ID: A0A024R4S0 Nearer transcript ids and distances: DQ892587:337 DQ895805:337 CU678002:341 KJ893617:341 AY364248:342 BT007298:342 CR457002:342 ENST00000596708.1:-406 ENST00000601220.5:-419 BC002502:-419 ENST00000597848.1:-436 ENST00000597209.1:-439 ENST00000600006.5:457 AK311974:-457 AK092868:-457 view more...

Gene_name: charged multivesicular body protein 2A Gene_symbol: CHMP2A Gene_synonyms: BC-2 CHMP2 VPS2 VPS2A Gene_source: HGNC:30216

TATA-Box annotation

---

Distance to TSS:	551
Nearest PromoterID:	NM_014453
Entrez ID:	27243
Nearest Unigene:	Hs.12107
Nearest Refseq:	NM_014453
Nearest Ensembl:	ENSG00000130724
Gene Name:	charged multivesicular body protein 2A
Gene Alias:	BC-2|BC2|CHMP2|VPS2|VPS2A
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CHMP2A p2@CHMP2A p3@CHMP2A p4@CHMP2A
Sample		p1@CHMP2A	p2@CHMP2A	p3@CHMP2A	p4@CHMP2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	13.25	15.39	3.31	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.73	20.64	2.23	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.54	15.43	3.09	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	14.14	16.63	2.70	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	14.40	18.67	2.92	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	14.54	14.73	3.68	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	20.26	23.97	4.36	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	12.35	23.98	5.57	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.52	24.58	4.92	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	14.49	35.94	12.75	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	19.40	28.30	8.49	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.45	27.24	8.13	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	20.31	42.88	1.61	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	19.55	40.29	1.50	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.37	40.62	1.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.07	33.95	2.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.20	33.63	1.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.56	34.17	2.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.99	40.52	2.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	21.36	38.81	1.65	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.52	42.37	2.81	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	22.27	44.88	2.07	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.77	39.81	2.07	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.23	40.28	2.67	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.90	41.54	3.10	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.67	37.98	0.95	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	36.81	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	19.33	47.62	3.30	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.22	43.13	3.07	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.82	35.83	4.16	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.91	36.64	1.67	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.32	42.79	2.54	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.67	36.51	1.90	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.07	36.12	3.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.38	39.64	2.62	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.48	42.35	2.30	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.09	45.58	2.45	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.34	40.30	3.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.53	45.38	2.97	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.37	37.21	3.84	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.76	47.99	3.53	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.45	39.97	2.34	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.78	43.87	3.59	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	22.38	43.18	3.32	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	23.89	46.98	3.01	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.62	47.23	2.79	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.87	42.22	4.56	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.31	43.81	3.87	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	26.57	45.72	5.03	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.33	40.04	2.43	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.46	44.68	2.05	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	28.46	45.36	2.45	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	181.90	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	16.68	39.74	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	14.91	42.75	3.31	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	36.07	61.24	9.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	36.28	45.01	2.30	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	25.60	42.13	5.51	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.70	40.79	2.89	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.46	34.58	7.86	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.74	29.61	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	38.13	3.36	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	67.67	33.44	7.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	41.11	31.26	4.08	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.50	33.47	5.52	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	16.33	32.66	3.19	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	129.31	80.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	165.85	197.44	39.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	16.09	30.23	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.35	33.72	3.47	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	17.83	34.25	2.81	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.51	32.46	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.09	33.41	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.76	34.55	1.53	0.31
Adipocyte - breast, donor1	11376-118A8	36.27	25.97	2.53	0.32
Adipocyte - breast, donor2	11327-117E4	33.21	16.20	2.25	0.48
Adipocyte - omental, donor1	11473-119C6	26.85	22.52	2.42	0.89
Adipocyte - omental, donor2	11474-119C7	33.64	30.65	2.24	1.49
Adipocyte - omental, donor3	11475-119C8	18.42	34.83	0.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	33.81	40.83	1.91	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	17.59	1.10	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	20.32	22.58	1.81	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	26.24	39.10	1.74	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	40.87	25.62	1.37	2.54
Adipocyte differentiation, day04, donor2	13022-139D7	29.60	22.65	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	38.19	22.58	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	39.38	24.69	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	58.15	19.95	2.57	1.77
Adipocyte differentiation, day08, donor2	13023-139D8	46.80	20.01	2.26	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	31.99	22.93	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	40.06	14.47	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	62.38	34.52	2.91	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	57.01	18.08	3.01	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	32.07	21.93	1.96	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	49.63	15.53	1.83	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	31.38	22.32	2.43	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	31.91	24.38	1.08	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	34.74	16.77	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	39.76	22.67	0.54	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	82.00	23.43	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	53.01	26.50	1.44	0.62
Anulus Pulposus Cell, donor1	11248-116E6	45.43	54.47	2.63	0.80
Anulus Pulposus Cell, donor2	11463-119B5	39.43	57.06	3.18	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	38.64	23.36	3.15	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	42.98	27.79	6.08	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	17.12	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	34.67	24.21	2.39	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	40.47	34.15	2.53	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.02	27.72	5.28	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	31.19	25.34	2.92	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	35.92	28.64	2.43	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	30.88	24.35	2.38	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	35.78	31.64	5.65	4.14
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	44.27	29.03	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	18.81	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.99	21.75	4.28	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	45.04	42.31	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.71	19.75	3.77	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	36.97	24.11	3.75	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.56	23.99	2.08	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	26.73	22.99	3.47	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	27.31	17.56	1.95	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.52	26.54	2.82	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	21.61	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	17.70	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.87	24.53	1.72	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	8.39	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	39.32	33.98	2.91	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.49	28.08	3.04	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	23.02	6.06	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	31.35	29.64	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.08	28.00	3.63	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.78	21.94	2.58	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	38.47	28.15	1.88	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	25.08	21.54	3.22	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	20.69	20.69	3.57	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.76	26.32	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.09	18.37	2.71	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	36.83	29.70	5.94	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	32.55	30.01	4.07	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.29	24.45	3.06	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.70	24.78	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	35.39	30.64	4.32	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.34	22.23	2.54	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	25.81	22.62	2.61	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	36.84	28.34	1.89	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.67	22.38	2.88	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	34.75	23.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	25.35	4.23	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.30	25.94	2.79	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.05	20.46	5.41	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	39.36	32.80	2.92	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.64	27.59	4.37	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	15.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	24.41	17.54	4.32	2.29
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	29.11	23.53	2.89	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.23	22.03	3.06	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	44.93	29.64	3.82	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	30.82	21.95	2.88	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	25.94	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	43.20	29.36	1.66	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	25.69	20.12	3.18	2.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	24.71	22.17	2.18	0.00
Astrocyte - cerebellum, donor1	11500-119F6	35.25	48.14	1.84	1.60
Astrocyte - cerebellum, donor2	11580-120F5	37.14	54.09	1.54	1.03
Astrocyte - cerebellum, donor3	11661-122F5	38.38	38.59	1.68	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	31.72	36.60	0.00	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	22.49	31.38	1.46	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	26.70	29.68	1.79	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	38.99	23.51	3.10	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	33.83	22.17	3.13	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	34.71	19.57	2.16	0.34
Basophils, donor1	12241-129G9	85.52	9.42	0.78	1.57
Basophils, donor2	12242-129H1	80.10	7.58	1.44	0.72
Basophils, donor3	12243-129H2	63.21	10.44	0.59	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	46.57	22.42	1.51	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	42.98	23.77	0.91	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	21.52	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	43.94	37.66	2.51	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	49.28	35.56	2.70	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	56.19	41.45	2.07	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	54.16	26.63	1.62	1.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.03	1.96	0.21	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	27.95	23.29	3.26	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.81	21.11	0.96	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	65.94	9.58	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	56.98	9.47	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	56.42	6.59	0.66	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	90.29	12.45	1.42	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	95.91	13.27	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	110.46	11.83	1.31	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	66.06	11.27	0.72	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	39.83	8.15	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	55.67	9.71	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	70.31	7.70	1.17	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	51.34	7.45	1.66	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	57.27	9.92	1.24	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	76.56	7.24	0.98	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	58.40	10.15	1.60	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	74.65	8.27	0.87	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	63.92	6.56	1.64	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.99	6.34	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	73.22	2.22	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	62.18	8.63	1.34	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	44.50	7.78	1.80	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	55.59	7.91	1.46	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	90.37	9.61	1.60	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	41.17	5.20	2.04	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	54.12	7.86	2.18	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	71.55	6.72	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	56.00	6.98	0.70	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	66.49	10.10	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	89.65	9.92	1.65	1.84
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	65.87	11.62	1.41	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	84.24	10.53	0.88	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	63.12	5.23	0.87	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	39.40	7.81	1.12	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	61.86	9.05	0.65	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	79.03	10.24	0.82	2.46
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	50.07	7.19	2.78	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	71.69	11.14	2.09	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	90.89	14.39	0.65	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	84.08	17.32	2.08	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	78.20	10.40	0.22	2.17
CD14+CD16- Monocytes, donor1	11788-124B6	157.90	17.44	0.93	1.56
CD14+CD16- Monocytes, donor2	11799-124C8	92.21	14.50	1.05	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	139.13	14.05	1.56	2.01
CD14-CD16+ Monocytes, donor1	11790-124B8	124.01	18.88	1.02	3.06
CD14-CD16+ Monocytes, donor2	11800-124C9	77.95	13.61	1.54	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	78.32	16.42	0.84	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	14.23	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	69.15	12.20	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	62.14	11.39	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	54.90	6.40	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	48.78	10.19	0.54	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	76.51	15.44	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	69.02	8.63	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	73.82	9.23	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	56.71	10.68	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	39.17	10.88	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	49.47	20.70	2.52	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	261.43	17.37	1.62	5.25
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	212.53	22.77	2.00	4.39
CD34+ Progenitors, donor1	11545-120B6	21.09	37.15	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	38.76	16.29	1.12	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	35.32	17.28	1.13	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	43.52	19.62	0.90	0.90
CD4+ T Cells, donor1	11225-116C1	49.63	6.07	1.79	1.07
CD4+ T Cells, donor2	11306-117C1	60.01	5.51	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	63.44	7.62	2.13	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	130.17	13.02	0.26	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	105.56	13.93	0.90	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	96.30	18.68	0.00	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	83.44	8.53	1.42	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	75.15	12.64	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	72.52	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	111.57	15.17	1.16	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	106.42	12.88	1.86	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	94.31	17.57	1.13	1.93
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	102.66	8.97	1.79	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	87.35	11.53	1.05	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	78.76	11.00	0.44	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	124.81	9.28	0.42	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	101.81	15.17	1.04	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	104.25	11.36	1.00	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	74.51	3.54	0.82	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	69.14	8.04	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	59.18	12.55	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	140.18	15.39	1.67	1.67
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	118.49	13.43	1.30	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	121.89	15.13	2.10	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	115.28	11.12	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	104.41	9.96	0.87	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	81.93	14.82	1.74	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	102.44	10.89	0.49	2.97
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	82.16	15.69	0.92	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	111.67	16.75	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	75.32	18.28	0.55	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	99.63	18.16	0.98	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	90.86	15.40	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	108.51	12.53	0.00	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	128.80	22.16	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	35.36	8.84	1.96	1.31
CD8+ T Cells, donor2	11307-117C2	31.16	9.39	1.88	0.38
CD8+ T Cells, donor3	11383-118B6	30.80	10.86	0.76	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.44	29.82	2.75	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	2.64	32.83	1.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.38	23.53	1.92	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.50	29.12	1.50	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	29.52	1.92	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.32	31.61	1.14	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.82	27.81	2.39	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.21	26.32	1.58	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.52	23.22	1.64	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.43	29.28	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.49	24.69	2.61	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.93	28.51	2.13	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.63	14.88	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1.82	19.13	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	23.12	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.68	32.05	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.32	27.62	1.44	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.59	23.57	3.30	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.44	26.30	2.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.46	26.14	4.61	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.21	20.20	2.56	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.59	24.48	2.29	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.15	26.41	2.36	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	21.94	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.01	44.97	4.01	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	3.50	35.67	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	53.09	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	63.97	34.73	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	37.06	33.10	0.99	1.98
Cardiac Myocyte, donor3	11686-122I3	40.09	31.04	1.68	1.89
Chondrocyte - de diff, donor1	11261-116G1	28.77	34.67	2.08	1.39
Chondrocyte - de diff, donor2	11338-117F6	29.14	35.54	2.84	0.00
Chondrocyte - de diff, donor3	11410-118E6	32.65	35.04	2.50	0.57
Chondrocyte - re diff, donor2	11339-117F7	73.41	49.24	1.79	2.69
Chondrocyte - re diff, donor3	11411-118E7	59.85	48.12	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	36.38	45.10	2.64	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	31.42	31.00	2.78	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	29.65	32.39	3.01	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	67.31	33.56	2.11	1.28
Corneal Epithelial Cells, donor1	11526-119I5	43.69	25.25	1.10	2.42
Corneal Epithelial Cells, donor2	11606-120I4	62.57	25.03	5.69	0.00
Corneal Epithelial Cells, donor3	11687-122I4	52.66	29.14	2.81	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	88.16	11.39	3.14	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	95.57	12.30	2.52	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	96.62	13.80	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	74.51	12.96	3.13	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	43.39	15.72	2.05	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	65.29	22.20	4.57	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	57.59	20.33	3.39	2.90
Endothelial Cells - Aortic, donor0	11207-116A1	55.20	25.02	2.67	2.50
Endothelial Cells - Aortic, donor1	11263-116G3	29.34	29.93	3.52	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	44.12	27.15	1.70	1.98
Endothelial Cells - Aortic, donor3	11412-118E8	38.53	27.92	2.75	3.15
Endothelial Cells - Artery, donor1	11264-116G4	35.78	15.42	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	34.59	20.47	1.41	1.65
Endothelial Cells - Artery, donor3	11413-118E9	55.57	31.56	1.58	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.88	20.39	1.33	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	46.25	22.82	3.04	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	42.57	18.32	0.28	3.38
Endothelial Cells - Microvascular, donor1	11265-116G5	34.76	24.07	2.38	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	36.97	24.99	3.12	3.64
Endothelial Cells - Microvascular, donor3	11414-118F1	39.27	24.81	0.57	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	34.41	27.21	2.00	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	53.98	21.49	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	39.88	17.02	1.49	2.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	43.89	16.95	1.30	2.17
Endothelial Cells - Umbilical vein, donor3	11400-118D5	43.84	14.29	0.61	1.22
Endothelial Cells - Vein, donor1	11267-116G7	22.75	30.71	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	30.04	20.96	2.10	2.10
Endothelial Cells - Vein, donor3	11416-118F3	28.89	24.96	1.73	1.57
Eosinophils, donor1	12244-129H3	91.48	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	633.70	18.15	6.60	8.25
Eosinophils, donor3	12246-129H5	542.16	17.83	3.57	14.27
Esophageal Epithelial Cells, donor1	11507-119G4	36.40	18.57	1.95	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	66.57	27.04	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	29.56	35.30	2.05	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	17.96	16.42	2.85	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	31.31	32.07	2.17	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	33.11	21.83	2.55	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	31.25	13.78	3.41	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	41.34	24.68	2.53	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.55	17.13	1.32	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	34.22	30.89	2.99	0.66
Fibroblast - Cardiac, donor1	11268-116G8	35.38	38.56	2.27	0.91
Fibroblast - Cardiac, donor2	11345-117G4	38.66	21.22	1.52	2.27
Fibroblast - Cardiac, donor3	11417-118F4	29.65	16.88	1.58	0.79
Fibroblast - Cardiac, donor4	11452-119A3	41.22	24.85	1.21	1.21
Fibroblast - Cardiac, donor5	11456-119A7	40.74	29.95	1.90	1.90
Fibroblast - Cardiac, donor6	11460-119B2	36.38	25.32	1.52	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	45.56	40.20	1.61	2.55
Fibroblast - Choroid Plexus, donor2	11572-120E6	41.42	30.20	2.59	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	38.08	16.11	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	33.67	49.36	1.15	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	39.69	32.73	1.19	0.51
Fibroblast - Dermal, donor1	11269-116G9	21.13	23.01	2.82	0.47
Fibroblast - Dermal, donor2	11346-117G5	41.04	31.60	7.08	0.47
Fibroblast - Dermal, donor3	11418-118F5	34.21	32.28	2.90	0.85
Fibroblast - Dermal, donor4	11450-119A1	23.29	23.63	2.15	0.23
Fibroblast - Dermal, donor5	11454-119A5	21.28	24.42	1.40	0.52
Fibroblast - Dermal, donor6	11458-119A9	21.60	24.85	1.62	0.49
Fibroblast - Gingival, donor1	11237-116D4	43.10	28.53	3.33	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	50.83	25.94	2.88	0.79
Fibroblast - Gingival, donor2	11318-117D4	30.97	24.64	1.84	0.92
Fibroblast - Gingival, donor3	11394-118C8	40.22	41.58	2.51	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	49.87	48.83	2.08	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	27.84	24.84	1.23	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	48.33	27.91	3.27	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	38.81	28.40	2.98	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.47	7.06	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	47.38	25.15	3.22	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	48.00	22.09	3.27	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.42	19.85	2.52	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	40.21	36.98	2.20	0.59
Fibroblast - Lung, donor1	11270-116H1	29.91	48.94	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	34.32	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	39.46	42.84	1.27	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	63.31	54.98	1.67	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	53.15	47.55	2.80	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	24.63	25.47	1.68	1.40
Fibroblast - Mammary, donor1	11540-120B1	51.56	30.45	3.65	1.62
Fibroblast - Mammary, donor2	11620-122A9	27.96	23.97	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	29.78	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.62	25.41	2.91	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	34.43	20.63	1.52	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	36.72	20.20	2.45	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.20	25.57	2.29	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.47	31.32	2.97	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	30.50	28.88	1.28	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.27	14.70	2.43	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	41.45	26.01	2.44	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	30.74	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	45.47	35.19	1.98	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.81	14.49	0.99	1.98
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	26.82	29.48	1.78	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	38.23	26.02	1.97	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	16.85	15.04	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	45.99	34.54	2.05	2.16
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	44.54	27.84	1.77	0.51
Fibroblast - skin normal, donor1	11553-120C5	41.84	37.57	2.95	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.06	13.63	1.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	47.92	30.94	2.51	1.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	30.83	26.29	0.60	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	38.03	29.16	1.57	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	42.74	46.50	0.85	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	17.74	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	47.83	26.84	1.81	2.24
Fibroblast - skin walker warburg, donor1	11554-120C6	31.21	27.33	2.53	1.86
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	41.24	34.97	4.86	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	132.96	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	128.99	20.92	2.61	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	55.47	11.79	1.73	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	44.76	14.57	2.34	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	48.80	14.82	3.83	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	10.72	50.53	4.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	11.49	47.22	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	25.39	54.20	3.71	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.96	86.86	2.76	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	8.45	44.75	3.20	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	17.44	46.36	4.36	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.29	81.42	3.44	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	10.44	37.83	4.57	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	23.88	42.45	7.52	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	16.53	55.26	2.40	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	19.46	62.68	4.31	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	13.70	45.40	3.49	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	15.24	52.41	1.86	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	16.20	51.36	1.52	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.62	33.54	1.83	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	18.03	42.44	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	20.06	47.58	1.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.73	48.74	1.09	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	26.89	52.89	1.77	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	22.89	45.78	1.27	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	23.24	43.12	1.56	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.96	37.71	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	27.14	47.16	1.36	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	24.12	31.57	1.42	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.35	59.62	1.25	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.27	47.48	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.45	51.90	1.88	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.22	36.19	1.58	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.78	36.14	2.25	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.87	48.69	1.24	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.10	54.19	1.73	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.18	33.52	1.50	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.92	45.41	1.54	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.67	67.03	2.34	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.99	35.98	1.78	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	22.13	66.39	1.92	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.22	46.33	1.61	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.62	37.01	0.95	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.06	43.79	2.43	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	33.56	41.29	1.46	0.94
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.27	50.72	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	32.26	47.69	1.68	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.66	33.52	1.76	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.03	22.46	0.80	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.97	21.27	2.30	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	39.51	28.37	2.33	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	49.61	39.85	1.90	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	39.45	31.52	1.29	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	41.89	30.27	1.32	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	41.65	40.66	4.96	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	35.22	29.28	2.11	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.88	28.25	1.21	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	30.75	39.65	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.52	58.72	2.59	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	16.02	61.94	3.39	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.98	65.06	1.64	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.33	46.31	3.13	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.11	51.14	5.37	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.22	65.03	3.69	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	44.55	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.47	43.32	4.25	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	56.16	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	50.43	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.62	48.50	4.56	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.41	51.48	2.47	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	33.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.14	50.34	2.52	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.26	49.03	1.96	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	12.58	48.65	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	17.81	56.30	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.28	51.97	3.74	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	77.26	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	13.74	72.16	3.44	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	17.76	63.93	1.18	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	55.91	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.54	47.63	2.90	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.04	56.15	2.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	89.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.91	47.28	2.69	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.54	65.52	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.72	75.58	2.01	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.41	76.67	1.54	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.38	66.41	2.40	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	84.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	17.46	83.52	4.25	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.67	76.04	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	19.84	73.25	3.56	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	19.54	81.76	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	17.76	88.80	2.47	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	113.32	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.09	91.60	1.75	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	13.17	107.09	2.63	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	80.53	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.92	59.69	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.44	54.35	2.91	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	36.52	29.67	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	45.32	31.60	2.08	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	59.60	41.60	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.54	26.32	1.90	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	24.65	25.48	2.92	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	31.45	37.02	6.03	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.59	39.33	5.23	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	29.35	40.27	2.73	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	34.32	42.08	4.81	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	31.38	35.25	6.02	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	30.14	32.51	4.95	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.62	41.97	5.23	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	31.91	35.68	3.26	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	27.23	33.00	4.49	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.94	38.61	1.68	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	28.56	20.77	0.43	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	7.93	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	51.14	39.15	3.17	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	50.13	31.97	3.63	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	26.23	23.78	2.97	0.87
Hepatocyte, donor1	11523-119I2	71.43	24.21	0.00	2.42
Hepatocyte, donor2	11603-120I1	60.33	25.86	2.15	2.15
Hepatocyte, donor3	11684-122I1	74.24	25.16	3.07	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	22.19	14.36	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	98.75	36.01	3.67	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.76	23.05	2.20	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	35.02	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	20.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	29.07	29.07	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	35.04	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	35.60	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	20.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	45.71	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	37.36	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	31.68	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	25.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	29.12	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	31.04	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	47.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.30	28.34	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	29.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	27.13	30.36	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	24.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	35.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	27.71	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.93	19.73	2.10	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	71.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	36.17	28.13	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	32.31	21.24	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.04	27.85	0.94	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	21.77	19.95	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	32.28	32.28	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	25.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	28.06	24.87	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	32.81	23.69	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	47.41	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	31.42	22.14	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	29.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	31.79	24.69	3.40	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	36.88	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	12.57	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	27.82	26.42	2.78	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	44.26	2.21	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	35.66	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.01	30.52	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	24.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	38.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	44.80	25.60	1.07	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	20.78	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	14.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	37.74	20.25	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	51.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	24.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	33.84	35.95	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	32.48	13.55	2.53	0.33
Keratinocyte - epidermal, donor2	11349-117G8	39.24	27.52	1.17	1.17
Keratinocyte - epidermal, donor3	11421-118F8	47.80	22.62	1.14	0.38
Keratinocyte - oral, donor1	11251-116E9	60.05	37.35	1.82	1.82
Keratocytes, donor1	11527-119I6	29.91	68.77	4.13	1.72
Keratocytes, donor2	11607-120I5	38.67	21.09	3.52	0.00
Keratocytes, donor3	11688-122I5	20.75	38.14	1.19	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	173.64	37.36	8.79	4.40
Lens Epithelial Cells, donor1	11529-119I8	18.34	25.89	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	34.48	41.52	1.50	2.08
Lens Epithelial Cells, donor3	11690-122I7	45.01	20.69	2.12	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	43.40	22.77	1.42	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	39.91	22.33	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	47.85	28.33	1.89	2.36
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	40.33	32.80	3.23	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	38.77	20.80	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	48.73	29.43	1.73	1.83
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.94	24.62	2.05	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	43.74	26.80	1.77	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	48.98	32.51	0.56	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	34.41	19.38	0.79	3.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.55	27.34	1.94	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	45.73	32.59	1.48	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	42.86	25.43	2.09	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	37.45	25.76	2.39	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	51.23	29.39	1.92	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	37.26	27.72	1.54	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	39.90	25.87	1.87	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	57.09	32.02	1.65	3.48
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	50.68	26.66	1.97	2.96
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	45.98	26.36	1.46	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	58.50	35.60	1.74	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	40.25	21.82	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	41.74	23.43	1.62	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	52.07	34.97	2.72	2.27
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	38.36	25.40	0.52	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.04	22.20	1.47	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	50.98	31.88	1.65	1.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	41.27	28.20	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	43.84	21.83	3.01	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	56.41	34.57	1.59	2.23
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.89	28.11	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.74	20.18	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	46.71	28.99	1.98	1.61
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	47.39	22.21	2.22	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	32.37	23.47	1.48	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	46.06	29.84	1.79	2.20
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.42	23.48	1.61	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.00	18.26	1.22	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	52.77	32.75	2.24	2.66
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.69	23.11	2.84	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	37.81	16.97	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	49.95	30.19	1.40	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	36.17	26.14	2.15	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	49.33	25.81	1.96	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	45.44	34.14	1.65	2.35
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	40.47	22.77	1.86	2.72
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	36.37	24.84	2.05	1.79
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	46.84	35.21	3.58	2.98
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	104.24	15.86	9.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	77.48	27.62	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	74.96	20.04	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	68.97	17.35	3.39	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	61.19	20.40	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	76.59	23.35	2.80	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	70.08	14.43	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	71.37	16.65	3.57	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	77.36	12.44	2.94	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	67.76	19.78	2.91	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	81.03	20.71	4.95	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	73.57	18.29	2.57	1.49
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	64.19	21.57	2.05	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	62.46	21.17	3.53	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	55.97	19.32	4.66	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	55.52	12.73	4.58	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	69.90	17.88	4.00	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	68.59	14.74	2.65	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	56.45	20.25	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	68.50	15.49	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	68.93	18.74	2.08	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	68.38	19.34	2.80	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	77.28	17.52	3.09	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	69.67	15.10	2.90	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	63.37	21.52	3.59	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	64.73	22.13	1.66	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	67.16	14.85	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	61.22	18.44	1.84	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	67.93	18.42	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	70.99	16.12	2.30	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	69.63	11.32	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	81.23	17.23	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	65.97	14.46	2.71	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	56.73	17.95	2.15	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	75.44	20.91	5.23	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	79.52	16.72	2.97	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	61.17	21.97	3.02	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	81.35	20.55	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	87.96	23.66	1.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	73.00	19.31	2.41	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	81.05	19.91	2.13	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	75.96	15.47	2.41	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	60.12	19.32	1.61	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	64.64	17.51	0.67	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	74.45	19.63	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	80.24	20.93	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	58.18	15.87	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	72.03	17.21	1.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	58.15	13.81	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	84.32	27.59	5.37	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	77.94	18.74	2.96	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	49.87	16.00	3.76	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	77.43	22.12	3.52	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	72.55	17.12	2.70	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	60.24	15.49	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	75.71	19.60	3.56	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	66.47	15.64	1.56	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.74	15.83	3.30	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	69.54	13.49	4.67	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	70.45	18.82	3.50	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	55.35	16.21	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	64.92	22.97	2.65	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	76.76	15.81	2.70	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	61.27	13.17	2.03	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	72.57	20.19	2.40	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	79.11	18.68	3.18	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	52.26	13.98	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	65.71	17.98	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	61.56	14.06	1.52	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	54.74	18.59	2.07	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	63.49	25.40	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	72.57	15.85	1.27	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	50.64	25.06	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	49.42	18.96	2.30	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	69.94	15.94	2.57	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	46.69	15.56	0.71	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	62.99	24.40	1.70	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	60.74	12.90	3.74	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.81	14.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	55.95	23.38	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	68.30	19.51	0.93	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	60.21	18.06	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	73.25	20.85	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	73.14	16.97	2.02	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	52.31	12.85	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	59.57	20.45	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	69.52	18.24	2.85	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	74.39	20.71	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	76.06	24.62	2.74	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	69.04	15.15	3.12	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	74.09	21.06	2.08	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	74.93	21.88	1.99	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	91.46	12.47	10.39	0.00
Macrophage - monocyte derived, donor1	11232-116C8	81.14	13.22	1.37	2.05
Macrophage - monocyte derived, donor2	11313-117C8	77.62	12.11	2.20	2.57
Macrophage - monocyte derived, donor3	11389-118C3	78.39	14.42	2.49	1.31
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	36.11	14.34	0.53	1.59
Mallassez-derived cells, donor2	11929-125I3	41.99	19.81	3.17	1.11
Mallassez-derived cells, donor3	11930-125I4	37.39	17.37	2.64	1.25
Mammary Epithelial Cell, donor1	11273-116H4	35.67	43.94	3.49	0.60
Mammary Epithelial Cell, donor2	11350-117G9	29.53	24.61	1.74	0.58
Mammary Epithelial Cell, donor3	11422-118F9	29.93	19.46	2.24	0.50
Mast cell - stimulated, donor1	11487-119E2	97.62	25.08	6.10	1.36
Mast cell, donor1	11563-120D6	59.04	18.71	1.41	1.73
Mast cell, donor2	11565-120D8	99.26	20.51	0.00	1.49
Mast cell, donor3	11566-120D9	100.63	14.18	1.13	1.58
Mast cell, donor4	11567-120E1	88.29	11.52	0.18	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	89.93	22.40	2.22	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	33.27	16.93	0.58	2.33
Mast cell, expanded, donor5	11939-126A4	80.19	18.58	1.03	2.06
Mast cell, expanded, donor8	11941-126A6	42.34	8.87	1.00	1.00
Melanocyte - dark, donor1	11502-119F8	42.29	24.18	1.19	1.79
Melanocyte - dark, donor2	11582-120F7	28.72	31.49	4.15	0.69
Melanocyte - dark, donor3	11663-122F7	69.18	26.08	3.77	3.04
Melanocyte - light, donor1	11274-116H5	33.38	25.15	4.00	1.18
Melanocyte - light, donor2	11351-117H1	52.55	38.90	2.73	2.73
Melanocyte - light, donor3	11423-118G1	36.42	20.81	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	72.78	26.97	3.12	2.19
Melanocyte, donor2 (MC+2)	12739-135I3	79.88	22.59	3.23	4.03
Melanocyte, donor3 (MC+3)	12837-137B2	55.98	29.20	2.14	1.61
Meningeal Cells, donor1	11493-119E8	35.48	26.55	0.99	1.61
Meningeal Cells, donor2	11573-120E7	38.29	44.01	0.44	0.88
Meningeal Cells, donor3	11654-122E7	25.10	15.97	0.57	1.06
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.65	33.36	2.28	2.28
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	26.37	18.32	2.52	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	40.74	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	28.78	27.47	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	27.27	17.22	1.44	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.92	26.47	2.75	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	41.22	30.16	5.03	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	24.83	30.33	1.76	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.76	24.11	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	24.35	27.42	1.43	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.21	52.91	1.52	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	32.34	35.69	1.86	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	32.50	47.63	1.97	1.45
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.24	40.95	0.89	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	44.38	7.01	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	29.46	36.50	1.92	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	46.08	17.72	3.19	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.28	48.47	0.63	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	29.03	38.46	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	40.57	14.05	3.45	2.92
Mesothelial Cells, donor2	12156-128G5	48.55	16.01	5.51	2.50
Mesothelial Cells, donor3	11402-118D7	46.54	15.75	2.60	1.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	136.38	8.10	2.70	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	90.63	21.92	0.99	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	75.38	17.67	3.24	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	117.54	20.74	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	66.95	15.81	2.17	2.79
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	57.87	15.14	3.32	1.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	125.07	2.32	2.32	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	76.08	17.27	1.25	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	80.53	12.57	5.59	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	64.83	15.85	1.42	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	58.21	11.88	2.38	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	25.65	17.10	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	72.56	7.96	1.77	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	64.59	16.34	3.04	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	126.33	5.26	2.63	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	66.21	13.58	1.70	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	79.19	11.05	6.45	4.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	52.46	10.13	1.19	1.79
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	85.51	11.74	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	62.73	15.31	1.25	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	58.94	10.46	2.14	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	92.33	14.37	3.32	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	54.57	10.36	3.22	2.30
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	57.84	12.62	2.94	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	51.57	11.62	1.43	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	53.85	13.09	1.50	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	68.91	11.56	2.89	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	82.55	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	49.28	10.95	1.10	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	75.54	12.17	5.58	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	152.44	18.23	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	67.13	11.69	1.63	2.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	60.88	14.41	2.06	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	94.86	4.36	4.36	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	62.47	14.42	2.40	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	56.43	8.00	1.20	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	76.79	6.86	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	57.57	17.52	1.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	85.62	6.12	10.19	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	56.93	16.20	0.88	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	73.94	12.14	3.31	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	87.09	8.97	5.76	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	59.25	13.64	2.73	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	84.90	6.96	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	121.54	13.26	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	55.38	12.65	1.71	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	59.52	11.38	4.38	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	74.93	11.72	1.78	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	51.06	15.15	2.24	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	62.34	13.30	4.57	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	66.43	15.73	3.50	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	39.22	9.95	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	42.99	21.70	4.17	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	72.19	7.22	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	66.50	9.24	4.62	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	60.90	15.37	2.85	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	52.23	14.37	2.49	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.91	15.81	2.59	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	48.90	15.01	4.29	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	52.09	9.53	7.62	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	42.97	10.14	2.94	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	50.59	14.07	6.29	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	39.13	12.43	3.25	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.40	14.65	1.91	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	44.23	22.11	3.32	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	43.23	12.89	5.31	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	38.64	16.19	1.42	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	32.45	21.14	4.18	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	52.79	10.43	3.26	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.40	12.64	3.23	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	37.48	15.28	5.19	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	61.00	12.78	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	44.97	14.59	2.08	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	116.77	18.83	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	60.60	21.39	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	68.34	15.44	2.63	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	87.31	12.62	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	64.05	8.11	0.59	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	65.19	14.90	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	70.60	21.78	3.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	76.17	14.12	0.80	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	61.53	11.88	0.45	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	64.10	16.94	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	65.96	15.02	0.37	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	65.34	17.11	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	81.23	12.29	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	27.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	74.74	19.19	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	72.10	15.60	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	72.18	14.98	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	55.31	8.90	1.27	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	61.55	13.77	1.62	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	46.82	13.59	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	16.31	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.53	20.47	1.29	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	30.83	40.76	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.68	24.70	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	31.72	25.04	2.09	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	50.39	23.77	8.94	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	111.71	59.05	6.38	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.96	14.96	2.72	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	66.16	38.59	16.54	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.97	27.62	4.19	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	25.34	23.01	6.97	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.89	28.91	3.24	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.12	34.48	4.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	122.48	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.88	41.69	4.47	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	26.80	22.47	4.06	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.00	28.34	3.85	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.04	30.21	3.27	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.63	30.44	2.73	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	19.10	27.58	2.65	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.21	20.41	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	60.06	18.71	9.19	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.40	20.82	3.09	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	40.57	35.98	4.94	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	21.80	0.70	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.85	28.04	2.76	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.10	39.53	3.86	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	76.22	24.83	8.97	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	123.89	53.10	10.11	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	32.53	31.64	5.35	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	14.40	1.27	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	25.40	22.07	3.56	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.02	39.49	3.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	99.31	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.99	37.32	3.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	43.73	30.66	3.61	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.70	21.03	3.57	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	40.86	5.57	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	26.49	32.16	7.57	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.97	23.14	1.30	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	28.76	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	45.23	29.85	3.62	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	26.46	3.53	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	23.93	2.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	20.34	39.68	2.98	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.46	27.56	2.68	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.31	33.57	4.23	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.24	27.19	3.32	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	22.36	4.74	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	66.42	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	41.46	4.88	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.03	25.18	3.46	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.53	34.81	1.51	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	26.11	3.16	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	60.08	27.21	7.94	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	60.69	15.17	5.06
Myoblast, donor1	11241-116D8	32.67	17.14	5.59	1.12
Myoblast, donor2	11322-117D8	49.86	31.07	5.56	0.96
Myoblast, donor3	11398-118D3	37.84	23.88	5.38	1.51
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.96	31.81	2.04	0.88
Natural Killer Cells, donor1	11230-116C6	29.52	11.69	1.54	1.85
Natural Killer Cells, donor2	11311-117C6	37.39	11.76	2.11	0.30
Natural Killer Cells, donor3	11387-118C1	36.07	14.72	1.66	1.10
Neural stem cells, donor1	11275-116H6	37.02	41.74	6.17	0.73
Neural stem cells, donor2	11352-117H2	25.03	44.29	7.70	1.93
Neurons, donor1	11494-119E9	35.27	80.79	6.83	0.00
Neurons, donor2	11574-120E8	35.01	42.93	4.18	1.54
Neurons, donor3	11655-122E8	41.11	64.13	4.93	1.64
Neutrophils, donor1	11233-116C9	322.95	4.64	3.71	5.57
Neutrophils, donor2	11314-117C9	286.99	2.90	2.90	2.90
Neutrophils, donor3	11390-118C4	423.92	11.00	2.44	6.11
Nucleus Pulposus Cell, donor1	11252-116F1	38.59	40.96	1.07	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	38.42	43.96	2.28	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	38.31	59.76	2.21	0.80
Olfactory epithelial cells, donor1	11933-125I7	23.68	23.81	1.51	1.10
Olfactory epithelial cells, donor2	11934-125I8	25.76	30.40	3.33	0.43
Olfactory epithelial cells, donor3	11935-125I9	27.81	27.58	1.93	0.45
Olfactory epithelial cells, donor4	11936-126A1	26.98	27.27	1.56	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	50.55	24.67	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	56.58	57.21	2.55	1.49
Osteoblast - differentiated, donor2	11353-117H3	40.01	35.44	5.72	2.29
Osteoblast - differentiated, donor3	11425-118G3	11.79	27.31	1.86	0.00
Osteoblast, donor1	11277-116H8	67.62	55.50	4.50	1.37
Osteoblast, donor2	11354-117H4	25.28	18.26	2.11	1.40
Osteoblast, donor3	11426-118G4	42.83	45.50	1.60	1.42
Pancreatic stromal cells, donor1	11249-116E7	38.92	27.71	2.61	1.60
Pericytes, donor1	11491-119E6	40.17	43.39	0.78	1.22
Pericytes, donor2	11571-120E5	44.37	47.76	1.13	1.36
Pericytes, donor3	11652-122E5	45.78	38.45	3.46	2.24
Perineurial Cells, donor1	11499-119F5	26.45	25.09	1.81	1.02
Perineurial Cells, donor2	11579-120F4	42.60	28.16	2.39	1.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	72.35	6.37	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	72.97	8.33	1.96	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.99	9.06	0.78	0.39
Placental Epithelial Cells, donor1	11278-116H9	62.66	24.39	4.07	1.91
Placental Epithelial Cells, donor2	11355-117H5	39.92	27.72	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	34.16	23.56	0.59	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	26.90	20.57	1.90	1.27
Preadipocyte - breast, donor1	11467-119B9	26.26	25.32	2.44	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	33.94	14.10	1.17	1.44
Preadipocyte - breast, donor2	11328-117E5	39.40	26.57	2.93	1.13
Preadipocyte - omental, donor1	11468-119C1	29.52	20.57	2.77	0.43
Preadipocyte - omental, donor2	11329-117E6	35.35	23.13	2.62	0.87
Preadipocyte - omental, donor3	11403-118D8	28.51	26.64	3.01	0.86
Preadipocyte - perirenal, donor1	11469-119C2	29.53	47.24	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	62.65	33.78	3.99	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	32.76	26.38	2.83	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	39.34	31.33	2.04	1.70
Preadipocyte - visceral, donor1	11280-116I2	36.05	31.20	4.10	0.75
Preadipocyte - visceral, donor2	11357-117H7	24.85	32.67	2.30	1.38
Preadipocyte - visceral, donor3	11429-118G7	29.36	26.75	2.30	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	55.21	26.85	4.53	0.60
Prostate Epithelial Cells, donor2	11331-117E8	24.37	13.41	2.03	0.81
Prostate Epithelial Cells, donor3	11404-118D9	67.36	20.76	0.86	1.22
Prostate Stromal Cells, donor1	11254-116F3	37.13	27.34	3.76	0.46
Prostate Stromal Cells, donor2	11332-117E9	36.94	33.71	2.87	1.97
Prostate Stromal Cells, donor3	11405-118E1	37.33	30.24	2.50	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	42.34	29.93	0.73	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.36	22.80	1.39	1.11
Renal Epithelial Cells, donor1	11517-119H5	28.91	26.38	1.52	1.52
Renal Epithelial Cells, donor2	11597-120H4	35.57	25.61	2.85	0.71
Renal Epithelial Cells, donor3	11678-122H4	36.31	22.44	1.38	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	29.96	19.74	0.00	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	34.90	26.01	0.81	2.70
Renal Glomerular Endothelial Cells, donor3	11675-122H1	36.41	13.32	1.55	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	19.96	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	26.41	35.87	2.20	0.88
Renal Mesangial Cells, donor2	11598-120H5	38.87	38.25	0.63	1.88
Renal Mesangial Cells, donor3	11679-122H5	28.85	31.90	1.39	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	39.99	33.28	1.07	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	37.11	38.80	2.53	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.10	28.16	1.74	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.52	42.26	2.59	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.74	44.63	1.99	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	31.90	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.05	46.67	3.51	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	96.22	22.72	0.53	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	12.51	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	16.51	9.36	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	35.38	19.14	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	17.94	13.13	1.04	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	17.08	8.34	0.89	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.51	10.71	1.12	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.59	11.91	0.87	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	17.48	8.86	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.03	13.17	1.16	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.77	9.45	0.55	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	17.40	7.26	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	17.92	11.47	1.25	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	13.05	12.48	0.14	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.24	11.48	0.97	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	18.14	12.83	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.41	9.94	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	14.91	8.48	1.12	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	15.78	9.40	1.88	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	17.52	9.82	1.46	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.23	11.00	0.97	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.57	10.88	0.76	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.35	13.24	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	15.42	6.73	1.40	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.00	10.77	1.03	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.13	8.75	0.36	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.54	9.32	0.98	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	21.09	12.22	1.34	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	8.73	13.21	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	16.87	8.53	1.19	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	20.81	11.69	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	14.31	9.95	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	12.83	8.41	1.55	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	17.96	12.12	1.67	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.79	15.61	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.92	11.41	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.75	11.57	2.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.35	10.66	0.69	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.52	7.82	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	16.25	14.28	1.64	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.86	12.27	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	19.83	17.75	1.48	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	16.79	9.33	1.33	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.10	16.87	0.55	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.91	10.95	1.43	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.39	13.50	1.21	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.90	12.43	0.47	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	18.87	16.42	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	21.15	11.79	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	14.69	12.61	0.86	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	17.03	12.37	0.73	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	18.25	13.39	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.66	12.96	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	18.32	11.76	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.06	15.28	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	17.12	12.04	0.71	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.29	17.72	1.49	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	23.44	10.82	0.60	0.60
Schwann Cells, donor1	11498-119F4	32.16	40.06	1.13	0.94
Schwann Cells, donor2	11578-120F3	20.41	13.61	0.00	3.40
Schwann Cells, donor3	11659-122F3	26.07	19.28	0.88	1.10
Sebocyte, donor1	11220-116B5	37.80	19.72	2.19	1.10
Sebocyte, donor2	11301-117B5	38.60	14.71	3.68	1.84
Sebocyte, donor3	11378-118B1	42.46	36.07	2.68	1.24
Sertoli Cells, donor1	11255-116F4	34.79	26.51	4.97	3.31
Sertoli Cells, donor2	11333-117F1	31.07	19.77	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	22.26	51.56	2.02	0.79
Skeletal Muscle Cells, donor2	11358-117H8	28.19	49.15	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	42.64	53.51	3.34	0.00
Skeletal Muscle Cells, donor4	11451-119A2	26.71	36.76	1.57	1.89
Skeletal Muscle Cells, donor5	11455-119A6	21.11	33.45	1.64	1.49
Skeletal Muscle Cells, donor6	11459-119B1	22.93	28.47	1.54	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	42.59	45.36	1.13	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	46.09	38.95	1.71	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.69	29.37	1.69	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	30.25	32.02	2.95	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	43.43	37.64	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	34.54	57.93	3.30	1.24
Skin - palm, donor1	10286-104F7	182.66	83.27	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.57	11.53	2.16	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.90	9.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.84	15.84	2.34	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	34.75	16.12	1.39	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	36.85	19.41	1.41	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	26.22	15.86	1.90	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	53.74	18.14	1.20	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	32.09	51.22	3.09	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.90	14.23	2.45	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.78	41.15	5.29	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.66	24.31	2.21	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	57.10	30.71	4.33	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	54.08	46.35	4.64	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	49.04	3.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	45.38	35.27	5.59	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	32.36	32.14	3.55	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	46.73	36.36	4.74	2.30
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	38.42	28.00	1.30	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	46.07	31.90	2.66	3.25
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.45	19.08	3.99	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	36.60	34.32	1.46	1.14
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	37.14	41.71	2.13	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	47.48	57.58	5.81	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	36.72	12.24	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	51.50	41.48	1.43	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.56	26.55	2.80	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	39.82	32.29	3.01	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.64	36.11	3.36	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	57.70	34.65	4.64	2.94
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	33.41	30.18	5.39	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	36.76	32.58	3.29	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.73	33.80	1.71	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.14	45.00	1.65	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.72	23.05	5.54	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	40.50	28.90	3.64	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	51.93	52.53	2.42	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.43	15.63	2.38	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	28.76	30.63	1.73	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	39.95	34.94	3.76	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.30	23.84	1.78	1.78
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	50.96	31.36	3.47	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	50.26	63.76	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	37.47	16.80	5.17	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	53.48	39.07	4.65	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	41.91	27.26	4.04	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	36.35	26.64	2.51	2.82
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	29.20	33.92	2.95	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.24	27.41	2.58	1.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	42.51	39.71	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	50.66	26.62	2.73	2.16
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	54.31	38.75	4.08	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	44.94	41.74	1.32	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	32.56	29.49	3.63	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	40.47	35.36	2.01	1.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.90	35.24	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	47.22	27.16	5.87	2.20
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.35	37.34	1.77	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	29.55	31.01	1.76	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	26.63	25.27	2.53	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	38.35	24.59	7.14	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	24.18	24.18	4.09	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	33.78	30.18	5.75	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	35.49	22.14	7.10	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.03	14.97	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	22.35	27.68	3.56	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	23.96	35.14	2.00	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	28.01	25.50	2.51	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	28.42	29.34	2.29	0.00
Synoviocyte, donor1	11291-117A4	39.89	26.76	2.86	1.18
Synoviocyte, donor2	11368-117I9	32.02	31.51	2.01	1.17
Synoviocyte, donor3	11440-118H9	30.16	42.67	1.12	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	22.87	18.58	1.07	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	37.66	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	24.08	28.71	0.93	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	47.96	28.60	2.15	1.29
Tracheal Epithelial Cells, donor2	11369-118A1	47.55	20.10	1.93	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	41.23	23.48	1.15	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	93.87	24.48	1.23	1.48
Urethra, donor2	10319-105A4	75.53	19.78	0.00	0.00
Urothelial Cells, donor1	11520-119H8	31.61	21.52	0.80	1.06
Urothelial Cells, donor2	11600-120H7	48.47	20.03	0.80	1.20
Urothelial Cells, donor3	11681-122H7	46.30	18.57	0.46	1.15
Urothelial cells, donor0	11216-116B1	53.72	22.96	0.89	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	234.90	13.35	0.00	5.34
Whole blood (ribopure), donor090309, donation2	12180-129A2	263.05	7.15	0.00	8.58
Whole blood (ribopure), donor090309, donation3	12181-129A3	164.28	4.79	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	121.90	5.51	0.34	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	151.07	2.32	0.58	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	262.39	8.33	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	197.33	8.26	0.00	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	183.49	4.56	0.00	3.65
Wilms' tumor cell line:G-401	10809-111A8	8.88	26.77	1.85	0.62
Wilms' tumor cell line:HFWT	10597-108E3	28.16	39.60	2.64	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	316.47	141.33	15.08	6.14
achilles tendon, donor2	10292-104G4	49.60	18.60	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	42.07	28.05	2.55	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	39.01	14.86	0.93	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	23.86	19.23	2.14	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	33.47	24.76	2.45	2.99
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	30.92	17.99	0.84	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	51.60	20.94	2.11	2.11
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	38.11	53.35	5.44	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	37.01	11.90	2.20	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	18.78	32.26	2.86	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	43.10	24.07	5.44	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.43	14.54	3.13	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	15.60	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	50.66	31.14	2.56	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	64.98	26.93	2.59	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	37.70	23.38	2.34	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	62.74	23.70	3.72	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	85.54	38.66	2.88	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	38.37	24.86	7.98	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	58.03	21.34	6.40	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	57.93	21.53	6.07	3.03
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	54.64	17.09	4.09	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	30.52	16.71	3.79	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	40.36	20.68	7.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	55.75	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	47.46	49.34	6.40	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.53	25.73	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	39.36	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	64.53	33.21	3.53	1.88
adipose tissue, adult, pool1	10010-101C1	55.07	17.22	0.78	0.78
adipose, donor1	10184-103D4	14.66	64.51	5.28	1.17
adipose, donor2	10185-103D5	12.17	73.40	2.84	0.81
adipose, donor3	10186-103D6	12.25	37.58	2.18	0.54
adipose, donor4	10187-103D7	21.67	41.60	6.93	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	89.01	92.64	19.57	1.58
adrenal gland, adult, pool1	10081-102A9	105.49	25.46	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	32.15	45.49	2.00	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.73	25.01	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	86.48	14.84	0.46	0.93
amniotic membrane cells, donor2	12236-129G4	86.55	26.03	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	108.71	24.75	0.88	0.88
amygdala - adult, donor10196	10167-103B5	53.36	35.57	7.11	1.19
amygdala, adult, donor10252	10151-102I7	62.25	30.42	3.45	2.23
amygdala, newborn, donor10223	10360-105E9	40.99	19.69	4.20	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	19.10	84.67	1.02	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	45.23	24.49	4.85	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	24.05	27.39	1.00	0.67
aorta, adult, pool1	10052-101G7	59.82	30.79	0.98	1.18
appendix, adult	10189-103D9	85.77	21.73	1.16	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	35.08	36.80	2.06	0.69
artery, adult	10190-103E1	55.71	48.91	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	17.96	21.44	1.45	0.72
b cell line:RPMI1788	10427-106D4	32.71	38.22	2.23	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	37.73	22.75	2.77	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	51.01	21.14	2.48	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	41.68	37.33	4.02	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	59.84	35.23	3.36	2.24
bladder, adult, pool1	10011-101C2	60.84	26.29	1.20	1.09
blood, adult, pool1	10053-101G8	88.59	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	74.50	23.98	3.43	4.28
bone marrow, adult	10192-103E3	51.29	25.64	2.02	2.02
brain, adult, donor1	10084-102B3	57.40	33.83	4.10	0.00
brain, adult, pool1	10012-101C3	55.12	34.30	2.12	1.34
brain, fetal, pool1	10085-102B4	61.44	64.11	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	64.09	11.23	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	64.16	50.30	2.87	1.00
breast, adult, donor1	10080-102A8	40.41	25.25	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.22	29.35	2.29	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	49.48	45.76	5.57	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	154.48	60.78	10.36	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	64.15	32.92	5.33	0.24
carcinoid cell line:NCI-H1770	10703-109H1	26.33	100.15	7.05	0.00
carcinoid cell line:NCI-H727	10735-110B6	82.58	49.66	6.34	1.64
carcinoid cell line:SK-PN-DW	10719-109I8	13.63	35.18	1.58	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	12.24	26.88	2.66	0.27
caudate nucleus - adult, donor10196	10177-103C6	56.41	61.02	2.30	3.45
caudate nucleus, adult, donor10252	10164-103B2	90.02	30.29	2.51	1.67
caudate nucleus, adult, donor10258	10379-105H1	78.71	45.08	1.53	1.53
caudate nucleus, newborn, donor10223	10354-105E3	52.37	21.61	6.23	1.10
cerebellum - adult, donor10196	10173-103C2	55.35	61.18	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	39.93	19.64	0.64	1.28
cerebellum, adult, pool1	10083-102B2	30.36	44.15	2.07	0.69
cerebellum, newborn, donor10223	10357-105E6	67.25	24.91	1.66	0.00
cerebral meninges, adult	10188-103D8	63.79	41.35	3.28	1.26
cerebrospinal fluid, donor2	10294-104G6	35.81	32.89	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	26.17	52.05	1.87	1.01
cervical cancer cell line:ME-180	10553-107I4	60.49	45.07	2.65	2.15
cervix, adult, pool1	10013-101C4	63.83	21.84	0.94	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	75.94	51.28	7.66	3.20
chondrosarcoma cell line:SW 1353	10700-109G7	45.72	24.82	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	52.69	44.62	0.87	0.99
choriocarcinoma cell line:SCH	10785-110H2	24.89	38.81	1.60	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	26.80	27.04	2.85	0.24
chorionic membrane cells, donor1	12238-129G6	67.24	20.80	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	49.82	29.63	1.59	2.39
chorionic membrane cells, donor3	12240-129G8	96.71	27.47	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	33.32	12.12	4.04	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	68.39	19.98	3.27	2.11
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	36.96	26.61	4.22	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	32.36	27.48	1.80	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	39.18	31.20	3.63	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	35.43	25.25	1.22	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	39.75	24.15	0.88	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	41.18	25.02	2.61	2.61
clear cell carcinoma cell line:JHOC-5	10638-108I8	45.72	38.86	1.60	0.91
clear cell carcinoma cell line:TEN	10636-108I6	35.57	37.65	2.95	1.04
colon carcinoma cell line:CACO-2	10513-107D9	40.45	30.20	3.48	1.28
colon carcinoma cell line:COLO-320	10420-106C6	32.69	45.61	0.38	0.00
colon, adult, donor1	10082-102B1	84.49	32.13	0.00	0.00
colon, adult, pool1	10014-101C5	111.04	23.62	0.94	1.29
colon, fetal, donor1	10070-101I7	67.98	29.05	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	22.92	32.08	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	100.15	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2.55	34.42	1.70	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	4.83	35.77	3.32	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	8.04	30.74	2.82	0.42
corpus callosum, adult, pool1	10042-101F6	76.62	38.70	2.65	1.77
cruciate ligament, donor2	10295-104G7	60.79	25.94	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	35.31	45.75	0.80	0.80
diencephalon, adult	10193-103E4	60.00	38.88	5.28	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.51	11.02	1.15	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	59.75	35.90	2.31	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.24	19.50	10.83	1.20
ductus deferens, adult	10196-103E7	90.20	29.40	1.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	41.77	40.33	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.94	31.63	0.74	0.74
dura mater, adult, donor1	10041-101F5	66.40	28.08	2.97	1.32
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	20.43	73.28	17.10	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	43.27	60.18	13.90	2.87
embryonic pancreas cell line:1B2C6	10604-108F1	24.66	25.90	3.70	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	39.66	37.84	1.51	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	31.49	25.32	0.93	0.93
embryonic pancreas cell line:2C6	10603-108E9	48.60	24.96	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	73.07	125.36	15.08	3.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	61.44	51.47	3.99	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	60.14	11.90	2.25	1.93
epidermoid carcinoma cell line:A431	10426-106D3	62.47	38.57	1.89	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	54.22	39.70	4.29	0.77
epididymis, adult	10197-103E8	64.89	38.30	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.08	42.05	2.48	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.52	12.98	0.00	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.19	40.89	3.28	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	17.22	37.10	2.66	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.02	45.93	4.03	0.11
esophagus, adult, pool1	10015-101C6	98.32	17.94	0.85	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	73.89	43.46	3.26	2.50
eye - muscle inferior rectus, donor1	10272-104E2	70.02	43.46	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	56.81	42.08	2.10	0.00
eye - muscle medial, donor2	10299-104H2	66.97	59.53	1.49	0.00
eye - muscle superior, donor2	10297-104G9	50.45	35.54	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	37.89	17.49	2.91	2.91
eye, fetal, donor1	10054-101G9	65.59	44.24	2.29	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	21.80	42.44	4.49	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	22.55	41.31	10.45	1.66
frontal lobe, adult, pool1	10040-101F4	46.16	38.66	2.44	1.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	117.10	34.23	4.50	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	98.48	82.93	5.12	2.01
gall bladder, adult	10198-103E9	102.61	30.18	2.17	1.93
gamma delta positive T cells, donor1	11937-126A2	72.48	11.81	1.07	2.15
gamma delta positive T cells, donor2	11938-126A3	50.05	13.82	1.12	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	41.19	38.86	4.44	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	87.62	19.92	0.58	1.93
gastric cancer cell line:AZ521	10549-107H9	37.55	61.48	4.26	1.64
gastric cancer cell line:GSS	10560-108A2	41.19	44.85	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.98	47.75	4.57	1.37
giant cell carcinoma cell line:LU65	10487-107B1	13.65	9.75	0.80	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	37.79	39.33	2.80	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	41.90	29.43	9.98	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	24.91	5.28	0.95	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	25.70	4.21	0.42	0.84
glioblastoma cell line:T98G	10485-107A8	34.88	43.38	3.86	1.21
glioma cell line:GI-1	10413-106B8	12.30	16.40	2.05	0.59
globus pallidus - adult, donor10196	10175-103C4	83.82	68.52	6.56	1.46
globus pallidus, adult, donor10252	10161-103A8	90.80	40.03	1.95	0.24
globus pallidus, adult, donor10258	10367-105F7	87.63	36.97	6.85	0.00
globus pallidus, newborn, donor10223	10364-105F4	57.02	23.45	3.73	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	26.92	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	43.71	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	52.27	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	34.24	21.44	3.52	2.24
hIPS +CCl2, biol_rep1	14383-156B9	9.18	46.37	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	12.80	38.87	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	10.95	29.63	1.29	0.00
hIPS, biol_rep1	14380-156B6	1.44	23.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	4.12	28.12	2.06	0.69
hIPS, biol_rep3	14382-156B8	25.38	32.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	16.67	43.39	4.60	0.57
heart - mitral valve, adult	10205-103F7	55.01	27.80	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	70.34	38.70	1.31	0.26
heart - tricuspid valve, adult	10207-103F9	73.27	35.80	3.33	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	75.30	39.38	2.24	0.82
heart, adult, diseased, donor1	10051-101G6	105.18	38.32	0.85	0.85
heart, adult, pool1	10016-101C7	126.95	46.69	1.38	1.84
heart, fetal, pool1	10046-101G1	39.84	37.58	0.62	1.13
hepatic mesenchymal tumor cell line:LI90	10778-110G4	42.88	33.01	2.16	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	32.11	22.59	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	7.18	23.98	3.65	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	9.10	21.85	3.16	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	9.09	21.63	2.93	0.51
hepatoma cell line:Li-7	10484-107A7	32.25	43.60	4.89	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	33.06	30.75	5.13	1.21
hippocampus - adult, donor10196	10169-103B7	61.51	49.21	4.73	0.95
hippocampus, adult, donor10252	10153-102I9	57.56	26.94	3.27	1.22
hippocampus, adult, donor10258	10374-105G5	26.39	42.33	5.48	0.50
hippocampus, newborn, donor10223	10363-105F3	40.18	20.44	5.64	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	19.53	51.88	6.10	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	12.57	39.47	2.95	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	16.50	44.18	3.05	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	4.51	74.43	4.51	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	7.49	77.72	1.81	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	10.63	84.65	2.28	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	9.93	57.81	2.92	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	7.32	62.47	3.45	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	13.35	45.46	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.63	49.02	1.89	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	16.71	47.41	3.54	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	51.17	2.69	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	10.48	46.01	3.91	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.26	53.06	2.46	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.96	48.00	6.11	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	6.11	68.73	3.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.05	62.36	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	6.00	58.47	2.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.46	75.17	3.77	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	79.12	5.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.77	85.51	7.20	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	12.90	49.81	3.10	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	14.81	48.77	3.19	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.33	52.01	4.78	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	12.01	48.96	2.40	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.27	51.64	4.28	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	19.19	60.43	11.84	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.51	53.52	3.87	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.65	52.58	2.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	10.29	67.79	3.93	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	51.20	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	10.63	63.76	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.14	60.80	2.31	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.11	46.78	2.30	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	63.61	5.30	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	19.83	41.34	2.69	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.90	48.30	1.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.80	44.57	5.79	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.07	54.15	4.39	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	4.28	62.04	1.83	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	149.65	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.60	77.77	2.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	14.23	70.05	2.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	9.77	61.16	2.90	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	9.25	52.31	3.20	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	41.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	15.03	52.82	2.98	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	18.05	42.56	3.77	0.27
immature langerhans cells, donor1	11904-125F5	97.83	11.14	1.21	0.97
immature langerhans cells, donor2	11905-125F6	93.47	16.63	2.38	0.00
insula, adult, pool1	10039-101F3	55.46	36.06	4.07	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	23.09	22.76	1.30	0.65
kidney, adult, pool1	10017-101C8	120.05	25.33	2.40	2.30
kidney, fetal, pool1	10045-101F9	57.23	30.56	1.34	1.34
large cell lung carcinoma cell line:IA-LM	10509-107D5	37.64	59.36	1.85	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.45	43.96	2.49	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	41.84	45.69	3.30	0.55
left atrium, adult, donor1	10079-102A7	40.86	53.40	3.27	0.54
left ventricle, adult, donor1	10078-102A6	78.38	58.15	2.53	1.01
leiomyoblastoma cell line:G-402	10721-110A1	26.27	42.96	8.48	1.37
leiomyoma cell line:10964C	10569-108B2	39.88	24.79	5.03	0.72
leiomyoma cell line:15242A	10570-108B3	35.33	17.39	2.72	0.54
leiomyoma cell line:15425	10571-108B4	41.04	21.12	4.86	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	31.75	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	20.91	5.23	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	32.82	27.15	4.37	0.83
liposarcoma cell line:KMLS-1	10782-110G8	39.36	30.15	4.84	0.78
liposarcoma cell line:SW 872	10726-110A6	25.95	37.04	3.53	1.10
liver, adult, pool1	10018-101C9	71.14	40.68	3.40	1.78
liver, fetal, pool1	10086-102B5	40.45	27.28	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	45.79	33.25	7.00	0.87
locus coeruleus, adult, donor10252	10165-103B3	60.90	31.37	5.17	1.29
locus coeruleus, adult, donor10258	10375-105G6	28.78	29.91	4.51	0.56
locus coeruleus, newborn, donor10223	10362-105F2	46.69	12.20	5.47	0.84
lung adenocarcinoma cell line:A549	10499-107C4	65.32	46.36	5.40	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	62.74	19.30	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	59.45	41.26	3.16	1.05
lung, adult, pool1	10019-101D1	77.26	20.32	0.59	1.30
lung, fetal, donor1	10068-101I5	92.19	38.24	0.57	3.14
lung, right lower lobe, adult, donor1	10075-102A3	54.99	34.82	0.92	0.46
lymph node, adult, donor1	10077-102A5	61.06	34.56	2.84	0.47
lymphangiectasia cell line:DS-1	10727-110A7	39.89	23.23	1.97	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	20.07	8.90	1.36	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	62.86	11.04	3.40	0.00
mature adipocyte, donor1	12231-129F8	127.87	34.63	1.78	1.33
mature adipocyte, donor2	12232-129F9	104.80	36.73	1.45	0.83
mature adipocyte, donor3	12233-129G1	82.73	38.17	1.90	1.19
mature adipocyte, donor4	12234-129G2	79.49	26.06	0.53	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	78.15	33.36	5.72	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	43.99	55.27	6.77	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	54.44	29.43	2.57	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	52.42	45.75	3.18	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	72.08	23.03	6.40	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	57.88	39.83	3.21	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	69.82	31.41	3.82	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	23.12	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	57.41	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	40.56	26.20	4.67	1.79
medulla oblongata - adult, donor10196	10174-103C3	59.71	64.25	5.19	1.30
medulla oblongata, adult, donor10252	10155-103A2	55.11	26.16	0.77	1.24
medulla oblongata, adult, pool1	10038-101F2	56.57	31.26	3.84	0.65
medulla oblongata, newborn, donor10223	10361-105F1	52.08	15.28	5.21	1.74
medulloblastoma cell line:D283 Med	10838-111E1	7.31	34.54	2.44	0.44
medulloblastoma cell line:ONS-76	10759-110E3	41.70	33.99	7.34	1.59
melanoma cell line:COLO 679	10514-107E1	51.89	10.78	1.87	1.72
melanoma cell line:G-361	10465-106H6	39.36	59.99	3.80	1.63
meningioma cell line:HKBMM	10691-109F7	30.93	36.90	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	24.67	36.13	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	31.63	34.48	3.37	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	45.42	40.05	4.30	1.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.81	42.90	2.00	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	36.03	28.99	2.07	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	41.58	34.84	3.09	1.97
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	37.74	40.82	2.50	1.73
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	40.26	3.47	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	30.72	31.24	2.57	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	34.04	35.77	1.96	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	37.67	33.42	2.12	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	40.78	30.11	2.97	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	35.00	16.50	2.42	2.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.04	30.30	1.65	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	43.86	27.40	1.80	2.08
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.72	25.13	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	44.51	27.36	1.84	2.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	36.66	19.77	1.44	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	42.41	36.72	1.86	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.74	10.94	1.37	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.51	30.21	2.10	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.30	28.39	2.09	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	40.96	29.67	1.14	1.23
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.03	26.51	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	28.90	15.74	3.43	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	26.52	23.16	2.95	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.01	42.93	5.48	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	43.99	34.02	3.07	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.34	39.79	5.24	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.98	28.65	1.85	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	45.42	33.66	4.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	41.29	27.41	3.72	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.33	41.26	3.93	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	47.27	32.90	6.49	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	96.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	57.68	55.38	5.77	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	45.51	39.93	4.91	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	50.47	39.90	3.12	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	61.60	38.13	4.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	42.63	33.90	4.36	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	45.85	30.29	2.87	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	48.11	35.65	3.87	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	43.75	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	46.48	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	52.94	54.56	3.25	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	49.47	5.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	49.58	59.17	4.26	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	40.89	36.80	2.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	46.26	41.20	3.50	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	44.07	6.30	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	40.73	40.73	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	57.21	71.51	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	46.25	51.59	3.56	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	49.96	42.65	6.09	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	48.77	41.80	3.17	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	32.42	49.32	3.45	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	58.03	30.09	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	19.96	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	41.33	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.67	29.75	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	14.30	33.37	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	27.12	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.40	33.04	2.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	18.71	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	21.29	37.85	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	30.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	25.47	40.62	3.44	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	38.59	33.65	1.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	30.28	5.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.26	29.89	5.72	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	49.97	38.69	2.82	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	45.79	45.79	8.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	55.75	29.14	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.27	24.88	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	36.15	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	45.30	32.12	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.76	28.37	2.98	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.80	24.34	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	36.67	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	38.69	19.34	2.32	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	35.67	40.63	3.31	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	50.04	69.97	7.18	3.01
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	29.92	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	40.28	24.66	8.84	1.64
mesothelioma cell line:Mero-25	10850-111F4	19.06	40.40	2.27	0.45
mesothelioma cell line:Mero-41	10851-111F5	51.10	31.78	0.73	0.98
mesothelioma cell line:Mero-48a	10852-111F6	56.46	20.59	2.21	1.99
mesothelioma cell line:Mero-82	10853-111F7	21.02	45.73	3.42	1.31
mesothelioma cell line:Mero-83	10854-111F8	23.15	24.85	3.06	0.85
mesothelioma cell line:Mero-84	10855-111F9	44.99	30.08	2.78	0.51
mesothelioma cell line:Mero-95	10856-111G1	40.17	38.72	1.66	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	75.20	53.34	3.98	2.48
mesothelioma cell line:NCI-H226	10846-111E9	36.02	41.99	5.07	1.81
mesothelioma cell line:NCI-H2452	10848-111F2	23.74	30.92	1.20	0.17
mesothelioma cell line:NCI-H28	10845-111E8	58.02	40.97	8.40	0.76
mesothelioma cell line:No36	10857-111G2	19.90	27.73	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	34.41	25.20	2.44	0.81
migratory langerhans cells, donor1	11901-125F2	112.85	12.09	0.77	0.96
migratory langerhans cells, donor2	11902-125F3	106.73	11.85	0.85	1.34
migratory langerhans cells, donor3	11903-125F4	62.82	33.20	1.08	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.47	25.14	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.31	35.18	2.76	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	71.87	34.09	3.69	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.02	25.12	1.90	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.06	24.76	2.40	0.18
myeloma cell line:PCM6	10474-106I6	24.31	16.80	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	75.59	43.63	5.58	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.42	43.94	1.96	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	56.94	34.54	1.67	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	66.11	33.24	2.06	0.81
nasal epithelial cells, donor2	12227-129F4	51.34	24.29	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	5.98	58.67	4.14	0.00
neuroblastoma cell line:NB-1	10539-107G8	26.75	19.46	4.12	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	11.60	53.78	4.64	0.42
neuroblastoma cell line:NH-12	10555-107I6	10.25	60.38	2.42	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.37	28.94	5.93	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	27.24	33.74	2.22	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	11.27	24.96	1.41	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	38.78	28.61	5.09	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	29.54	30.08	2.40	0.80
neutrophil PMN, donor1	12133-128D9	208.25	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	132.81	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	322.00	9.47	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	21.99	28.41	0.17	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	164.10	78.45	5.60	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	33.66	33.66	1.60	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.11	27.59	2.10	1.31
nucleus accumbens, adult, pool1	10037-101F1	55.96	32.90	4.41	1.03
occipital cortex - adult, donor10196	10172-103C1	55.63	76.23	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	60.11	32.47	1.88	1.34
occipital cortex, newborn, donor10223	10355-105E4	54.96	26.57	6.91	1.09
occipital lobe, adult, donor1	10076-102A4	40.67	60.61	5.77	0.52
occipital lobe, fetal, donor1	10073-102A1	28.75	86.25	3.43	0.43
occipital pole, adult, pool1	10036-101E9	46.99	38.16	2.84	0.95
olfactory region, adult	10195-103E6	51.78	34.20	3.25	1.15
optic nerve, donor1	10277-104E7	118.06	30.02	6.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	21.19	26.31	2.39	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	30.09	38.47	2.61	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	59.77	20.83	2.54	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	20.68	15.13	0.35	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	34.10	24.40	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	68.21	28.03	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	10.18	13.15	0.85	0.42
ovary, adult, pool1	10020-101D2	51.89	26.29	1.40	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.65	42.90	9.53	0.92
pancreas, adult, donor1	10049-101G4	94.06	27.28	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	26.84	17.33	1.68	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	42.59	35.43	3.07	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	103.32	30.14	2.48	1.82
paracentral gyrus, adult, pool1	10035-101E8	48.42	34.05	4.12	1.19
parietal cortex, adult, donor10258	10373-105G4	60.92	42.57	1.47	2.20
parietal lobe - adult, donor10196	10171-103B9	57.37	48.91	8.46	0.94
parietal lobe, adult, donor10252	10157-103A4	47.89	24.80	1.71	1.43
parietal lobe, adult, pool1	10034-101E7	47.58	33.31	3.70	1.15
parietal lobe, fetal, donor1	10072-101I9	32.00	57.22	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	44.49	16.45	6.36	2.99
parotid gland, adult	10199-103F1	133.82	22.82	0.00	1.23
penis, adult	10200-103F2	60.69	40.82	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	24.17	29.38	2.42	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.32	33.07	1.31	0.58
pineal gland - adult, donor10196	10179-103C8	58.70	66.44	12.90	2.58
pineal gland, adult, donor10252	10160-103A7	43.82	53.89	8.29	1.78
pineal gland, adult, donor10258	10377-105G8	48.91	52.67	5.02	1.88
pituitary gland - adult, donor10196	10180-103C9	97.13	41.48	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	92.77	32.31	2.08	1.04
pituitary gland, adult, donor10258	10378-105G9	96.19	32.35	4.26	1.70
placenta, adult, pool1	10021-101D3	139.65	24.30	1.18	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	40.13	29.00	1.85	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	55.10	15.10	1.09	1.09
pons, adult, pool1	10033-101E6	37.78	26.08	4.91	0.95
postcentral gyrus, adult, pool1	10032-101E5	49.95	39.93	3.75	1.31
promyelocytes/myelocytes PMC, donor1	12132-128D8	69.02	6.27	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	82.62	38.56	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	21.85	41.51	4.22	0.29
prostate cancer cell line:PC-3	10439-106E7	94.56	65.34	7.80	3.99
prostate, adult, pool1	10022-101D4	53.05	22.22	0.27	0.82
putamen, adult, donor10196	10176-103C5	89.23	41.08	4.72	1.89
putamen, adult, donor10252	10152-102I8	109.80	37.25	5.88	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	25.13	28.41	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	66.44	37.93	4.11	2.17
putamen, newborn, donor10223	10365-105F5	57.72	18.74	6.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	32.88	10.18	3.20	0.87
rectum, fetal, donor1	10067-101I4	34.77	43.12	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	77.59	39.43	3.18	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	47.63	51.36	1.66	2.07
retina, adult, pool1	10030-101E3	57.95	34.49	2.29	0.70
retinoblastoma cell line:Y79	10475-106I7	11.17	58.98	5.72	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	7.38	22.13	1.60	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	41.34	33.46	3.94	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	43.20	48.50	6.82	0.76
salivary acinar cells, donor1	11771-123I7	31.72	32.21	1.46	0.49
salivary acinar cells, donor2	11772-123I8	38.00	32.36	2.07	0.55
salivary acinar cells, donor3	11773-123I9	82.76	37.74	0.66	1.32
salivary gland, adult, pool1	10093-102C3	158.43	17.73	1.14	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.09	21.58	1.43	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.40	24.33	1.88	0.59
seminal vesicle, adult	10201-103F3	117.98	37.56	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	57.33	20.16	2.19	2.67
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	62.15	26.17	1.76	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	52.18	14.05	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	102.76	36.67	8.87	2.96
signet ring carcinoma cell line:Kato III	10436-106E4	32.05	21.11	1.22	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	78.58	24.77	4.39	1.55
skeletal muscle - soleus muscle, donor1	10282-104F3	100.02	63.13	1.42	2.84
skeletal muscle, adult, pool1	10023-101D5	90.67	60.21	2.88	1.68
skeletal muscle, fetal, donor1	10066-101I3	23.12	78.39	1.01	0.00
skin, adult, donor1	10074-102A2	94.99	27.14	0.00	0.00
skin, fetal, donor1	10065-101I2	65.02	33.46	3.16	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.37	91.05	11.34	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	27.74	24.59	2.84	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	94.45	79.99	4.63	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	34.28	31.48	1.81	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.59	60.96	2.73	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	24.19	40.31	2.40	0.00
small intestine, adult, pool1	10024-101D6	185.73	15.77	0.96	2.15
small intestine, fetal, donor1	10064-101I1	52.09	41.28	3.69	2.46
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	83.60	44.11	7.18	2.05
smooth muscle, adult, pool1	10048-101G3	45.23	35.41	1.29	1.03
somatostatinoma cell line:QGP-1	10781-110G7	123.02	34.84	5.63	0.80
spinal cord - adult, donor10196	10181-103D1	50.01	32.81	4.82	0.46
spinal cord, adult, donor10252	10159-103A6	48.50	29.57	1.97	1.18
spinal cord, adult, donor10258	10369-105F9	57.42	48.43	2.77	1.38
spinal cord, fetal, donor1	10056-101H2	63.42	53.67	7.32	1.22
spinal cord, newborn, donor10223	10359-105E8	86.79	26.18	5.97	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	48.39	28.97	1.94	0.90
spleen, adult, pool1	10025-101D7	76.54	16.08	0.77	1.10
spleen, fetal, pool1	10044-101F8	65.39	16.77	0.24	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	37.68	26.60	2.90	1.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	74.05	26.20	1.14	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	85.62	39.49	3.84	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	56.69	53.56	7.82	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	88.13	31.63	5.07	3.04
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	64.81	33.46	3.81	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	17.35	10.15	0.85	0.00
stomach, fetal, donor1	10062-101H8	118.55	64.08	7.48	4.27
submaxillary gland, adult	10202-103F4	112.23	19.94	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	73.32	27.42	1.45	1.25
substantia nigra, adult, donor10258	10371-105G2	27.93	52.24	4.66	1.03
substantia nigra, newborn, donor10223	10358-105E7	51.58	12.01	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	11.92	28.43	3.90	0.00
temporal lobe, adult, pool1	10031-101E4	58.75	37.89	4.58	1.61
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	28.49	52.71	4.99	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	22.42	58.02	2.64	0.00
tenocyte, donor1	11763-123H8	47.48	31.07	2.44	2.09
tenocyte, donor2	11765-123I1	33.95	28.99	1.53	0.00
tenocyte, donor3	11768-123I4	38.92	27.80	2.59	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	4.25	13.60	0.68	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	14.64	45.63	6.47	0.77
teratocarcinoma cell line:PA-1	10807-111A6	9.45	38.28	2.01	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.31	8.38	1.78	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.24	16.64	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	35.88	14.29	2.40	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	24.10	4.56	1.95	0.33
testis, adult, pool1	10026-101D8	51.43	30.06	3.33	0.75
testis, adult, pool2	10096-102C6	58.64	47.36	2.71	0.45
thalamus - adult, donor10196	10168-103B6	60.72	49.68	7.73	0.00
thalamus, adult, donor10252	10154-103A1	72.36	30.79	1.41	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	36.95	26.17	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.52	24.87	4.12	1.65
thalamus, newborn, donor10223	10366-105F6	37.40	16.68	4.03	1.15
throat, adult	10209-103G2	95.87	25.72	0.50	0.50
throat, fetal, donor1	10061-101H7	52.71	39.00	2.13	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	13.71	13.32	1.19	0.20
thymus, adult, pool1	10027-101D9	66.41	13.22	1.69	1.19
thymus, fetal, pool1	10043-101F7	42.60	15.48	1.66	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	49.86	31.11	4.52	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	44.84	67.61	5.17	1.26
thyroid, adult, pool1	10028-101E1	96.49	29.86	1.03	0.65
thyroid, fetal, donor1	10060-101H6	82.26	43.50	2.37	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	55.43	3.08	3.08
tongue, adult	10203-103F5	78.15	25.58	2.79	0.93
tongue, fetal, donor1	10059-101H5	74.88	43.74	1.18	1.18
tonsil, adult, pool1	10047-101G2	105.69	15.23	1.00	0.80
trachea, adult, pool1	10029-101E2	96.77	19.47	1.47	1.55
trachea, fetal, donor1	10058-101H4	61.94	36.16	1.92	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.95	28.70	3.54	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	21.07	21.28	2.03	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	11.44	17.86	1.88	0.00
tridermal teratoma cell line:HGRT	10694-109G1	64.69	28.54	9.51	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	23.62	44.70	2.20	0.42
umbilical cord, fetal, donor1	10057-101H3	56.34	27.12	4.17	0.00
uterus, adult, pool1	10100-102D1	62.28	31.22	1.02	1.19
uterus, fetal, donor1	10055-101H1	44.54	49.15	1.02	0.51
vagina, adult	10204-103F6	37.48	8.40	0.00	0.65
vein, adult	10191-103E2	54.36	24.99	1.10	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.52	31.51	1.87	1.87